Ken Griffin’s Global X Scientific Beta Europe ETF SCID Stock Holding History

Ken Griffin’s Portfolio SCID Stock Details SCID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,754	Closed	-$598K	–	11128
2020 Q2	$598K	Sell	26,754 -311	-1%	-$6.53K	﹤0.01%	6751
2020 Q1	$517K	Buy	27,065 +15,602	+136%	+$370K	﹤0.01%	6410
2019 Q4	$298K	Sell	11,463 -2,394	-17%	-$59.9K	﹤0.01%	7595
2019 Q3	$333K	Buy	13,857 +966	+7%	+$23K	﹤0.01%	7415
2019 Q2	$313K	Sell	12,891 -7,313	-36%	-$179K	﹤0.01%	7526
2019 Q1	$487K	Buy	20,204 +7,885	+64%	+$186K	﹤0.01%	6828
2018 Q4	$271K	Buy	+12,319	New	+$301K	﹤0.01%	7435
2018 Q3	–	Sell	-8,532	Closed	-$230K	–	9944
2018 Q2	$230K	Sell	8,532 -25,878	-75%	-$725K	﹤0.01%	7652
2018 Q1	$958K	Buy	+34,410	New	+$976K	﹤0.01%	4876

Ken Griffin's SCID Position: Q3 2020 in Review

Ken Griffin sold out of Global X Scientific Beta Europe ETF (SCID) in Q3 2020, closing a stake of 26,754 shares — an estimated $598K sold.

Ken Griffin first reported a position in SCID in Q1 2018 and held it in 9 quarters. The position peaked at $958K in Q1 2018. 0 funds tracked by Wall St. Rank hold SCID as of Q3 2020.

Ken Griffin reported no remaining Global X Scientific Beta Europe ETF position as of Q3 2020 after selling out during the quarter.
Ken Griffin sold 26,754 Global X Scientific Beta Europe ETF shares in Q3 2020, an estimated $598K.
Ken Griffin first reported a position in Global X Scientific Beta Europe ETF in Q1 2018 and held it in 9 quarters.
Ken Griffin's Global X Scientific Beta Europe ETF position peaked at $958K in Q1 2018.
0 funds tracked by Wall St. Rank held Global X Scientific Beta Europe ETF as of Q3 2020.

Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.